Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Clinician's Roundtable

Drugmakers' Foray into the Combination Pill Market

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Why take two pills when you can just take one? Welcome to the latest phenomenon in healthcare: combination pills. Tim Walbert, president and chief executive officer of Horizon Therapeutics, tells host Bruce Japsen about the drug industry's push toward combining two or more treatments into one pill, and the potential benefits for us and for our patients. 

Recommended
Details
Presenters
Comments
  • Overview

    Why take two pills when you can just take one? Welcome to the latest phenomenon in healthcare: combination pills. Tim Walbert, president and chief executive officer of Horizon Therapeutics, tells host Bruce Japsen about the drug industry's push toward combining two or more treatments into one pill, and the potential benefits for us and for our patients. 

Schedule23 Oct 2024